ENTO

Entero Therapeutics
ENTO

Overview Fund Trends Analyst Outlook Journalist POV

5 hedge funds and large institutions have $3.31M invested in Entero Therapeutics in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $
Holders
5
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$300K

Top Sellers

1
-$131K
2
-$89K
3
-$57K
4
BlackRock
BlackRock
New York
-$53K
5
Goldman Sachs
Goldman Sachs
New York
-$43K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$997K
2
$841K
3
$709K
4
$330K
5
$300K
6
$52K
7
$51K
8
$14K
9
$7K
10
$5K
11
–
12
–
13
–